[1] Guan HZ, Ren HT, Cui LY. Autoimmune encephalitis:an expanding frontier of neuroimmunology[J]. Chin Med J (Engl), 2016, 129:1122-1127.
[2] Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies[J]. Ann NY Acad Sci, 2015, 1338:94-114.
[3] Hermetter C, Fazekas F, Hochmeister S. Systematic review:syndromes, early diagnosis, and treatment in autoimmune encephalitis[J]. Front Neurol, 2018, 9:706.
[4] Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15:391-404.
[5] Kelly PB, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B. Autoimmune encephalitis:pathophysiology and imaging review of an overlooked diagnosis[J]. AJNR Am J Neuroradiol, 2017, 38:1070-1078.
[6] Dubey D, Sawhney A, Greenberg B, Lowden A, Warnack W, Khemani P, Stuve O, Vernino S. The spectrum of autoimmune encephalopathies[J]. J Neuroimmunol, 2015, 287:93-97.
[7] McKeon A. The importance of early and sustained treatment of a common autoimmune encephalitis[J]. Lancet Neurology, 2013, 12:123-125.
[8] Sun MJ, Ma LH, Du ZH, Ma YM, Wang MX. Research process of autoimmune encephalitis[J]. Zhong Feng Yu Shen Jing Ji Bing Za Zhi, 2019, 36:274-279.[孙梦娇, 马莉花, 杜转环, 马玉梅, 王满侠. 自身免疫性脑炎研究新进展[J]. 中风与神经疾病杂志, 2019, 36:274-279.]
[9] Guan HZ, Cui LY. Standardization and individualization of diagnosis and treatment of autoimmune encephalitis[J]. Zhonghua Shen Jing Ke Za Zhi, 2020, 53:5-7.[关鸿志, 崔丽英. 自身免疫性脑炎诊疗的规范化与个体化[J]. 中华神经科杂志, 2020, 53:5-7.]
[10] Neurology Branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of autoimmune encephalitis in China[J]. Zhonghua Shen Jing Ke Za Zhi, 2017, 50:91-98.[中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识[J]. 中华神经科杂志, 2017, 50:91-98.]
[11] Lee SK, Lee ST. The laboratory diagnosis of autoimmune encephalitis[J]. J Epilepsy Res, 2016, 6:45-50.
[12] Chen XJ, Zheng B. Clinical diagnostic criteria for autoimmune encephalitis and its implication on treatment[J]. Zhongguo Lin Chuang Shen Jing Ke Xue, 2016, 24:336-340.[陈向军, 邓波.自身免疫性脑炎的诊断标准及其临床指导意义[J]. 中国临床神经科学, 2016, 24:336-340.]
[13] Pradhan S, Das A, Das A, Mulmuley M. Antibody negativeautoimmune encephalitis:does it differ from definite one[J]? Ann Indian Acad Neurol, 2019, 22:401-408.
[14] Jiang JX, Fewings N, Dervish S, Fois AF, Duma SR, Silsby M, Bandodkar S, Ramanathan S, Bleasel A, John B, Brown DA, Lin MW. Novel surrogate markers of CNS inflammation in CSF in the diagnosis of autoimmune encephalitis[J]. Front Neurol, 2020, 10:1390.
[15] Culler G, Bachman E, Van Haerents S. Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitis[J]. J Neuroimmunol, 2020, 347:577324.
[16] Aydos U, Arhan E, Akdemir ÜÖ, Akba? Y, Aydin K, Atay LÖ, Serdaroglu A. Utility of brain fluorodeoxyglucose PET in children with possible autoimmune encephalitis[J]. Nucl Med Commun, 2020, 41:800-809.